CNBC’s Jim Cramer on Monday touted the burgeoning bull market of medical gadgets, noting constructive earnings stories from associated companies throughout the board.

“It’s plain that we have an rising bull market in medical gadgets — we have heard the identical extremely constructive story from firm after firm,” Cramer stated. “I’m simply praying we get one other debt ceiling-related sell-off that drags down all the market and provides you an opportunity to purchase the medical device performs at an undeserved low cost.”

Over the previous few years of pandemic turmoil, tons of non-urgent surgical procedures have been postponed as hospitals inundated with Covid-19 sufferers struggled to supply crucial care. But because the disaster subsided, nonessential procedures returned, prompting an uptick in the sale of medical gadgets.

Cramer pointed to companies like Inmode, identified for growing minimally-invasive radio frequency gadgets primarily used for beauty surgical procedure, whose earnings report earlier this month confirmed consumables and repair income up 43%. However, Inmode inventory fell sharply in the wake of the report, doubtless as a result of the corporate didn’t replace its full-year forecast, Cramer stated. But Cramer chalked up these outcomes to overly-cautious executives, dubbing Inmode inventory a cut price.

Another potential boon is Johnson & Johnson, which reported a better-than-expected quarter in April, due in half to the success of its medical gadgets division, in accordance with Cramer.

“When it involves J&J, it is all about talc proper now — as in the lawsuit about their talc’s attainable hyperlink to ovarian most cancers,” Cramer stated. “That litigation danger is the true problem right here, not earnings.”

Cramer additionally highlighted Intuitive Surgical, which makes the robotic Da Vinci Surgical System and reported a “true beat and lift quarter.” Although Intuitive offered the identical variety of robotic surgical procedure techniques because the 12 months prior, the variety of such procedures worldwide elevated by 26% 12 months over 12 months, Cramer stated. Since Cramer spoke with Intuitive CEO Gary Guthart again in March, the corporate’s inventory is up 38%.

Also on Cramer’s radar is GE HealthCare, which he stated he bought for the Investing Club portfolio final week.

“This firm’s obtained a terrific diagnostic tools division, together with tons of scanners that are important for catching and monitoring Alzheimer’s,” Cramer stated. “As the FDA approves extra Alzheimer’s medicine, we’ll want extra of those machines simply to know if the brand new medicines are working.”

Sign up now for the CNBC Investing Club to observe Jim Cramer’s each transfer in the market.

Disclaimer The CNBC Investing Club Charitable Trust holds shares of Johnson & Johnson and GE HealthCare.